Molecular adaptations to psychostimulants in striatal neurons: Toward a pathophysiology of addiction

Neurobiology of Disease

Volumn 4, Issue 3-4, 1997, Pages 239-246

  Genova, Lisa ^a   Berke, Joshua ^a   Hyman, Steven E ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE RECEPTOR;

ADRENERGIC STIMULATION; CLINICAL FEATURE; DOPAMINE BRAIN LEVEL; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; DRUG TOLERANCE; ETIOLOGY; EUPHORIA; GENE EXPRESSION REGULATION; HABITUATION; HUMAN; HYPERACTIVITY; MOTIVATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTLESSNESS; REVIEW; SEROTONIN BRAIN LEVEL;

EID: 0030668565     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1997.0154     Document Type: Article

References (72)

1. Bals-Kubik R., Ableitner A., Herz A., Shippenberg T. S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264:1993;489-495.
2. Benloucif S., Galloway M. P. Facilitation of dopamine release in vivo by serotonin agonists: Studies with microdialysis. Eur. J. Pharmacol. 200:1991;1-8.
3. Benloucif S., Keegan M. J., Galloway M. P. Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J. Pharmacol. Exp. Ther. 265:1993;373-377.
4. Benmansour S., Tejani-Butt S. M., Hauptmann M., Brunswick D. J. Lack of effect of high-dose cocaine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Psychopharmacology. 106:1992;459-462.
5. Bergman J., Madras B. K., Johnson S. E., Spealman R. D. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251:1989;150-155.
6. Berke J., Hyman S. E., Gerfen C. Society for Neuroscience Abstracts. 1997;Society for Neuroscience, Washington DC.
7. Bhat R. V., Baraban J. M. Activation of transcription factor genes in striatum by cocaine: Role of both serotonin and dopamine systems. J. Pharmacol. Exp. Ther. 267:1993;496-505.
8. Bourtchuladze B., Frenguelli B., Blendy J., Cioffi D., Schutz G., Silva A. Deficient long-term memory in mice with a targeted mutation of the cAMP responsive element binding (CREB) protein. Cell. 79:1994;59.
9. Breiter H. C., Gollub R., Weisskoff R., Kennedy D., Makris N., Goodman J., Kantor H., Gastfriend D., Berke J., Riorden J., Mathew T., Rosen B. R., Hyman S. E. Human brain activation during cocaine induced euphoria and craving. Neuron. 1997.
10. Calabresi P., Mercuri N., Stanzione P., Stefani A., Bernardi G. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement. Neuroscience. 20:1987;757-771.
11. Carew T. J. Molecular enhancement of memory formation. Neuron. 16:1996;5-8.
12. Carpenter M. B. Core Text of Neuroanatomy. 1991;Williams & Wilkins, Baltimore.
13. Cepeda C., Buchwald N. A., Levine M. S. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. Natl. Acad. Sci. USA. 90:1993;9576-9580.
14. Cole A. J., Bhat R. V., Patt C., Worley P. F., Baraban J. M. D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58:1992;1420-1426.
15. Cole R. L., Konradi C., Douglass J., Hyman S. E. Neuronal adaptation to amphetamine and dopamine: Molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron. 14:1995;813-823.
16. 3. Br. J. Pharmacol. 92:1987;881-894.
17. Deisseroth K., Bito H., Tsien R. W. Signaling from synapse to nucleus: Postsynaptic CREB phosphrylation during multiple forms of hippocampal synaptic plasticity. Neuron. 16:1996;89-101.
18. Diaz J., Levesque D., Lammers C. H., Griffon N., Martres M-P., Schwartz J-C., Sokoloff P. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience. 65:1995;731-745.
19. 2+. Proc. Natl. Acad. Sci. USA. 88:1991;5061-5065.
20. Dash P. K., Hochner B., Kandel E. R. Injection of the cAMP responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation. Nature. 345:1990;718-721.
21. Fosnaugh J. S., Bhat R. V., Yamagata K., Worley P. F., Baraban J. M. Activation of arc, a putative effector immediate early gene, by cocaine inrat brain. J. Neurochem. 64:1995;2377-2380.
22. Genova L. M., Hyman S. E. 5-HT3 receptor activation is required for the induction of striatal c-Fos and the phosphorylation of ATF-1 by amphetamine. Soc. Neurosci. Abstr. 291:1997;10.
23. Ginty D. D., Bonni A., Greenberg M. E. Nerve growth factor activates a ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell. 77:1994;713-725.
24. Graybiel A. M., Moratalla R., Robertson H. A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA. 87:1990;6912-6916.
25. Heimer L., Harlan R. E., Alheid G. F., Garcia M. M., De Olmos J. Substantial innominata: A notion which impedes clinical-anatomic correlations in neuropsychiatric disorders. Neuroscience. 76:1997;957-1006.
26. Henriksen S. J., Giacchino J. Functional characteristics of nucleus accumbens neurons: Evidence obtained from in vivo electrophysiological recordings. Limbic Motor Circuits and Neuropsychiatry. 1993;CRC Press, Boca Raton.
27. Henry D. J., White F. J. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258:1991;882-890.
28. Hope B., Nye H. E., Kelz M. B., Self D. W., Iadarola M. J., Nakabeppu Y., Duman R. S., Nestler E. J. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other treatments. Neuron. 13:1994;1235-1244.
29. Hope B., Kosofsky B., Hyman S. E., Nestler E. J. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci. USA. 89:1992;5764-5768.
30. Houk J. C., Davis J. L., Beiser D. G. Models of Information Processing in the Basal Ganglia. 1995;MIT press, Cambridge.
31. Hurd Y. L., Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse. 13:1993;357-369.
32. Hyman S. E. Addiction to cocaine and amphetamine. Neuron. 16:1996;901-904.
33. Jaber M., Cador M., Dumartin B., Normand E., Stinus L., Bloch B. Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience. 65:1995;1041-1050.
34. Jacobs B. L., Azmitia E. C. Structure and function of the brain serotonin system. Physiol. Rev. 72:1992;165-215.
35. 3NDD. J. Pharmacol. Exp. Ther. 262:1992;356-364.
36. Karler R., Calder L. D., Chaudhry I. A., Turkanis S. A. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
37. Kelly A. E., Throne L. C. NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res. Bull. 29:1992;247-254.
38. Kleven M. S., Woolverton W. L., Seiden L. S. Lack of long-term monoamine depletions following repeated or continuous exposure to cocaine. Brain Res. Bull. 21:1988;233-237.
39. Konradi C., Cole R. L., Heckers S., Hyman S. E. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14:1994;5623-5634.
40. Konradi C., Levesque J. C., Hyman S. E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci. 16:1996;4231-4239.
41. Koob G. F., Bloom F. E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
42. Kosofsky B. E., Genova L. M., Hyman S. E. Substance P phenotype defines specificity of c-fos induction by cocaine in developing rat striatum. J. Comp. Neurol. 351:1995;41-50.
43. Kotter R. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Prog. Neurobiol. 44:1994;163-196.
44. Levine M. S., Altemus K. L., Cepeda C., Cromwell H. C., Crawford C., Ariano M. A., Drago J., Sibley D. R., Westphal H. Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice. J. Neurosci. 16:1996;5870-5882.
45. Lipska B. K., Jaskiw G. E., Arya A., Weinberger D. R. Serotonin depletion causes long-term reduction of exploration in the rat. Pharmacol. Biochem. Behav. 43:1992;1247-1252.
46. Lyons D., Friedman D. P., Nader M. A., Porrino L. J. Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys. J. Neurosci. 16:1996;1230-1238.
47. Maldonado R., Blendy J. A., Tzavara E., Gass P., Roques B. P., Hanoune J., Schutz G. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science. 273:1996;657-659.
48. Markou A., Koob G. F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Psychopharmacology. 4:1991;17-26.
49. Mirenowicz J., Schultz W. Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature. 379:1996;449-451.
50. 2A. Behav. Brain Res. 73:1996;163-167.
51. Nguyen T. V., Kosofsky B., Birnbaum R., Cohen B. M., Hyman S. E. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine and amphetamine. Proc. Natl. Acad. Sci. USA. 89:1992;4270-4274.
52. O'Brien C. P., Childress A. R., McLellan A. T., Ehrman R. Classical conditioning in drug-dependent humans. Ann. N.Y. Acad. Sci. 654:1992;400-415.
53. Parsons L. H., Justice J. B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:1993;195-199.
54. Peris J., Boyson S. J., Cass W. A., Curella P., Dwoskin L. P., Larson G., Lin L. H., Yasuda R. P., Zahnister N. R. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmacol. Exp. Ther. 253:1990;38-44.
55. Pfeiffer A., Brandt V., Herz A. Psychotomimesis mediated by kappa opiate receptor. Science. 233:1986;774-776.
56. Post R. M., Weiss S. R. B., Pert A. Sensitization and kindling effects of chronic cocaine administration. Hammer R. Cocaine: Pharmacology, Physiology and Clinical Strategies. 1995.
57. Pulvirenti L., Maldonado-Lopez R., Koob G. F. NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res. 594:1992;327-330.
58. Pulvirenti L., Swerdlow N. R., Koob, G. F. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats. Neurosci. Lett. 103:1989;213-318.
59. Pulvirenti L., Swerdlow N. R., Koob G. F. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol. Biochem. Behav. 40:1991;841-845.
60. 3. Eur. J. Pharmacol. 186:1990;327-330.
61. Robertson L. M., Kerppola T. K., Vendrell M., Luk D., Smeyne R. J., Bocchiaro C., Morgan J. I., Curran T. Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron. 14:1995;241-252.
62. Robinson T. E., Berridge K. C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
63. Schultz W., Dayan P., Montague P. R. A neural substrate of prediction and reward. Science. 275:1997;1593-1599.
64. Self D., Nestler E. J. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:1995;463-496.
65. Sheng M., Thompson M. A., Greenberg M. E. CREB: A Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science. 252:1991;1427-1430.
66. Spanagel R., Herz A., Shippenberg T. S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA. 89:1992;2046-2050.
67. Steiner H., Gerfen C. R. Dynorphin regulates D1 dopamine receptor mediated responses in the striatum: Relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by immediate-early gene induction. J. Comp. Neurol. 376:1996;530-541.
68. Surmeier D. J., Song W-J., Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16:1996;6579-6591.
69. Surmeier D. J., Bargas J., Hemmings H. C. Jr., Nairn A., Greengard P. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron. 14:1995;385-397.
70. Tecott L. H. Serotonin receptor diversity: Implications for psychopharmacology. Adv. Neurosci. 1994;331-350.
71. Tella S. R., Ladenheim B., Andrews A. M., Goldberg S. R., Cadet J. L. Differential reinforcing effects of cocaine and GBR-12909: Biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system. J. Neurosci. 16:1996;7416-7427.
72. Tork I. Anatomy of the serotonergic system. Ann. N.Y. Acad. Sci. 600:1991;9-33.